Jean Jacques Bienaime, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 10,000 shares at $93.99 ($940K) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Scheduled sale ($940k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |